Journal article · 2022 · Open access
74P Management of early-stage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer in a real-word setting in Germany: A patient perspective
Annals of Oncology, 33, S156–S157 · Published 1 May 2022 · DOI 10.1016/j.annonc.2022.03.090
In brief
“74P Management of early-stage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer in a real-word setting in Germany: A patient perspective” is a 2022 journal article by Christian Jackisch and 8 co-authors, published in Annals of Oncology. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read at Annals of Oncology.
- Citations
- 0
- Authors
- 9
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Jackisch, C., Banys-Paluchowski, M. J., Korfel, A., Stoffregen, C., Otto, T., Brown, J., Sanderson, I., Rider, A., & Lüftner, D. (2022). 74P Management of early-stage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer in a real-word setting in Germany: A patient perspective. Annals of Oncology, 33, S156–S157. https://doi.org/10.1016/j.annonc.2022.03.090
MLA 9
Jackisch, Christian, et al. “74P Management of early-stage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer in a real-word setting in Germany: A patient perspective.” Annals of Oncology, vol. 33, 2022, pp. S156–S157. https://doi.org/10.1016/j.annonc.2022.03.090.
Chicago
Jackisch, Christian, Malgorzata Joanna Banys-Paluchowski, Agnieszka Korfel, C. Stoffregen, T. Otto, Jaqueline Brown, Isaac Sanderson, Alex Rider, and Diana Lüftner. 2022. “74P Management of early-stage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer in a real-word setting in Germany: A patient perspective.” Annals of Oncology 33: S156–S157. https://doi.org/10.1016/j.annonc.2022.03.090.
Harvard
Jackisch, C. et al. (2022) ‘74P Management of early-stage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer in a real-word setting in Germany: A patient perspective’, Annals of Oncology, 33, pp. S156–S157. doi:10.1016/j.annonc.2022.03.090.
IEEE
C. Jackisch et al., “74P Management of early-stage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer in a real-word setting in Germany: A patient perspective,” Annals of Oncology, vol. 33, pp. S156–S157, 2022, doi: 10.1016/j.annonc.2022.03.090.
BibTeX
@article{jackisch2022management,
title = {{74P Management of early-stage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer in a real-word setting in Germany: A patient perspective}},
author = {Jackisch, Christian and Banys-Paluchowski, Malgorzata Joanna and Korfel, Agnieszka and Stoffregen, C. and Otto, T. and Brown, Jaqueline and Sanderson, Isaac and Rider, Alex and Lüftner, Diana},
journal = {Annals of Oncology},
year = {2022},
volume = {33},
pages = {S156--S157},
doi = {10.1016/j.annonc.2022.03.090},
url = {https://doi.org/10.1016/j.annonc.2022.03.090}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- early breast cancer
- hormone receptor-positive breast cancer
- HER2-negative breast cancer
- patient perspectives
- patient satisfaction
- coping with illness
- patient involvement in treatment decisions
- adjuvant therapy
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Jackisch, C., Banys-Paluchowski, M. J., Korfel, A., Stoffregen, C., Otto, T., Brown, J., Sanderson, I., Rider, A., & Lüftner, D. (2022). 74P Management of early-stage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer in a real-word setting in Germany: A patient perspective. Annals of Oncology, 33, S156–S157. https://doi.org/10.1016/j.annonc.2022.03.090
How many times has this paper been cited?
0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Annals of Oncology: sign in and open the full text from this page.
Who wrote this paper?
Christian Jackisch, Malgorzata Joanna Banys-Paluchowski, Agnieszka Korfel, C. Stoffregen, T. Otto, Jaqueline Brown, Isaac Sanderson, Alex Rider, Diana Lüftner.
What is the DOI of this paper?
10.1016/j.annonc.2022.03.090, permanently at https://doi.org/10.1016/j.annonc.2022.03.090. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.